Mapping of Human Cognition

Recruiting N/A Interventional Study
Epilepsy Brain Tumor
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
75 (estimated)
Sponsor
The University of Texas Health Science Center, Houston · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to compare organization of normal brain function as detected using Functional magnetic resonance imaging (fMRI) in normal subjects as opposed to patients with epilepsy or brain tumors, to ascribe precise anatomic labels (including Brodmann Areas) and functional significance to each region involved in cognitive processes as detected by cortical stimulation mapping (CSM)…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * patients with medically refractory epilepsy who are scheduled to undergo or have previously undergone placement of sub-dural electrodes (including depth electrodes) to localize the site of seizure onset and to map the locations of critical language and motor regions * patients…
Contacts

Nitin Tandon, MD

713-500-5456

Nitin.Tandon@uth.tmc.edu

CONTACT

Eliana M Klier

713-500-5442

Eliana.Klier@uth.tmc.edu

CONTACT